Question 1

What is PathFree Technologies raising?

Accepted Answer

PathFree Technologies is offering a limited campaign-capital opportunity in connection with its three-night New York Investor Dinner Campaign. The offering is intended to comprise Campaign Capital Units, each consisting of an equity component and a separate contingent Campaign Performance Right. Terms are subject to definitive documents, board approval, and counsel confirmation.

Question 2

What will the Campaign Capital fund?

Accepted Answer

Up to $50,000 of Campaign Capital is intended to support the preparation and execution of the New York investor dinner campaign, including venue, production, demonstration technology, and host and investor experience. Final allocations may change within the approved campaign budget, and the use-of-proceeds disclosure in the final offering memorandum will control.

Question 3

What is the initial offering amount?

Accepted Answer

The initial offering is intended to be five Campaign Capital Units, representing $25,000 on an all-or-none basis, subject to the definitive offering documents.

Question 4

Can PathFree raise more than $25,000?

Accepted Answer

Yes. The issuer has reserved an expansion option for up to five additional Campaign Capital Units, for a maximum aggregate offering of $50,000, subject to board authorization and the terms of the definitive documents.

Question 5

What is the maximum Campaign Capital offering?

Accepted Answer

The maximum offering is intended to be $50,000, represented by ten Campaign Capital Units, subject to definitive documents and acceptance by PathFree.

Question 6

What happens if the full $50,000 is raised?

Accepted Answer

If the full $50,000 maximum offering is raised, PathFree Technologies intends to announce a second three-night New York investor presentation series. The timing, venue, format, and final decision are subject to board approval, available resources, and market conditions.

Question 7

What is the price of one Campaign Capital Unit?

Accepted Answer

The proposed price is $5,000 per Campaign Capital Unit, subject to the definitive offering documents.

Question 8

How many shares are included in a Unit?

Accepted Answer

Each Campaign Capital Unit is proposed to include 1,000 shares of PathFree Technologies Common Stock at a proposed price of $5.00 per share, subject to the definitive offering documents.

Question 9

Do investors retain their PathFree equity if the dinners do not produce capital?

Accepted Answer

Yes. Investors retain their PathFree Common Stock regardless of whether the dinners generate Qualified Raise Proceeds. Equity ownership is the constant; the performance payment is opportunity-based.

Question 10

What is the Campaign Performance Right?

Accepted Answer

The Campaign Performance Right is a separate contingent contractual right that may entitle the holder to a performance payment if PathFree receives a defined level of Qualified Raise Proceeds attributed to the dinner campaign during the applicable measurement period. It is not interest, a guaranteed return, a redemption obligation, a fixed-income product, or a guarantee that any capital will be raised.

Question 11

What happens if Qualified Raise Proceeds are below $500,000?

Accepted Answer

If Qualified Raise Proceeds are less than $500,000, no performance payment is earned under the illustrative schedule. The investor still retains the equity component of the Campaign Capital Unit.

Question 12

What occurs at the $500,000 milestone?

Accepted Answer

At $500,000 in Qualified Raise Proceeds, the applicable performance percentage is proposed to be 50% of the Campaign Capital contributed, subject to the definitive documents and verification.

Question 13

What occurs at the $1.5 million milestone?

Accepted Answer

At $1,500,000 in Qualified Raise Proceeds, the applicable performance percentage is proposed to be 100% of the Campaign Capital contributed, subject to the definitive documents and verification.

Question 14

What occurs at the $5 million milestone?

Accepted Answer

At $5,000,000 or more in Qualified Raise Proceeds, the applicable performance percentage is proposed to reach a maximum of 200% of the Campaign Capital contributed, subject to the definitive documents, verification, and any caps or conditions stated there.

Question 15

Is a performance payment guaranteed?

Accepted Answer

No. The performance payment is contingent on achievement of defined milestones, may never become payable, and is not guaranteed, secured, or interest-bearing.

Question 16

Is the investment repaid or redeemed after 90 days?

Accepted Answer

No. The Campaign Capital Units are equity, not a loan or debt instrument. There is no repayment, redemption, maturity date, or fixed return schedule. The reference to 90 days relates to the intended campaign reconciliation timeline, not a return of capital.

Question 17

What does “90 days” mean?

Accepted Answer

The campaign measurement period is intended to continue through the 75th day following the final qualifying dinner, with any final reconciliation intended by approximately the 90th day, subject to the definitive documents, verification, legally available funds, and applicable law.

Question 18

What are Qualified Raise Proceeds?

Accepted Answer

Qualified Raise Proceeds means proceeds actually received, cleared, verified, and attributed to the New York dinner campaign under the definitive documents, after applying any exclusions, holdbacks, or adjustments specified there. Only amounts that satisfy those criteria count toward milestones.

Question 19

Who determines whether proceeds qualify?

Accepted Answer

PathFree Technologies, with appropriate verification and in accordance with the definitive documents, determines whether proceeds qualify. The process is subject to the terms, conditions, and dispute-resolution provisions of the definitive documents.

Question 20

What is Borex Capital’s role?

Accepted Answer

Borex Capital’s role is to organize the private dinner settings, facilitate introductions, invite a targeted investor audience, coordinate applicable logistics, distribute PathFree-approved materials, and conduct appropriate follow-up. Borex Capital does not guarantee attendance, diligence, investment commitments, Qualified Raise Proceeds, a performance payment, liquidity, appreciation, or any particular investment outcome.

Question 21

Is Borex Capital a partner of PathFree Technologies?

Accepted Answer

No. PathFree Technologies has engaged Borex Capital to organize and facilitate the private New York investor presentation evenings. Borex Capital is not a product-development, clinical, strategic, joint-venture, or corporate partner of PathFree.

Question 22

Who presents during the investor evenings?

Accepted Answer

Dr. Perry M. Brunette, Ph.D., CEO & Founder of PathFree Technologies, will personally present PathFree Technologies and its flagship product, AiMediQ™ powered by datasyteAI™, discuss the company and offering, and answer investor questions.

Question 23

Are the three evenings different presentations?

Accepted Answer

No. Each evening is intended to provide a complete, stand-alone PathFree presentation to a different invited investor group. The evenings are not three separate themed chapters.

Question 24

Does Borex Capital guarantee that PathFree will raise money?

Accepted Answer

No. Borex Capital facilitates introductions and follow-up. Prospective investors make their own independent decisions, and no attendance, diligence, commitment, investment, or capital-raise result is guaranteed.

Question 25

Will 30 investors attend each evening?

Accepted Answer

30 targeted investors are expected to be invited per evening. The number invited is not a guarantee of attendance. Actual attendance, engagement, diligence activity, commitments, and investments may vary.

Question 26

How many investors are expected to be invited?

Accepted Answer

30 targeted investors are expected to be invited per evening, and 90 invitations are contemplated across the three-evening program. These figures are targets, not confirmed attendance commitments.

Question 27

Are attendee counts guaranteed?

Accepted Answer

No. The figures reflect targeted invitations, not confirmed attendees. Attendance depends on confirmations, schedules, and other factors. Neither PathFree nor Borex Capital guarantees attendance at any evening.

Question 28

Is PathFree the only company presenting?

Accepted Answer

Yes. PathFree Technologies is intended to be the sole presenting company during the three-evening program. Each evening is structured as a complete, single-company presentation and discussion.

Question 29

Who may participate in the offering?

Accepted Answer

The offering is intended for investors satisfying the eligibility requirements in the definitive documents. Under a Rule 506(c) structure, all purchasers must be accredited investors and PathFree must take reasonable steps to verify accredited status.

Question 30

How is accredited-investor status verified?

Accepted Answer

PathFree intends to take reasonable steps to verify accredited-investor status in a manner consistent with Rule 506(c), which may include reviewing tax returns, bank or brokerage statements, credit reports, or third-party verification letters, as specified in the definitive documents.

Question 31

Can I invest directly through this website?

Accepted Answer

No. This website does not accept subscriptions or investor funds. Prospective investors must request information, complete the required review process, satisfy eligibility requirements, receive definitive documents, and be accepted by PathFree.

Question 32

How do I receive the confidential offering documents?

Accepted Answer

Submit an information request through this website. PathFree Technologies reviews the request, confirm eligibility and suitability, and provide next steps for receiving confidential materials.

Question 33

What risks should I consider?

Accepted Answer

An investment in PathFree Technologies is speculative and involves a high degree of risk, including development-stage company risk, product and regulatory risk, market and commercial risk, capital-formation risk, and the risk of total loss. Prospective investors should review the complete confidential offering materials and consult their own legal, tax, accounting, and financial advisers.

Question 34

Who should I contact with questions?

Accepted Answer

Use the information request form on this website. PathFree and Borex Capital will respond to qualified inquiries through the review process established in the definitive documents.

Frequently asked questions

Structure, process, and contingency

Confidential materials are provided only after review.

Where would you like to go next?

Start here

The New York evenings

The investment

Questions